Gamble Jones Investment Counsel / NVSN
Gamble Jones Investment Counsel’s Novartis AG Position
Does Gamble Jones Investment Counsel own Novartis AG (NVSN)? Yes — 143.3K shares worth $13M (+0.98% of its 13F portfolio) as of Q4 2022, down from 145.4K shares the prior filed quarter.
Position Value
$13M
Q4 2022
Shares
143.3K
% of Portfolio
+0.98%
Quarters Held
17
currently held
Position History NVSN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 143.3K | $13M | +0.98% |
| Q3 2022 | 145.4K | $11M | +0.90% |
| Q2 2022 | 144.7K | $12M | +0.90% |
| Q1 2022 | 146.9K | $13M | +0.80% |
| Q4 2021 | 147.9K | $13M | +0.77% |
| Q3 2021 | 147.3K | $12M | +0.79% |
| Q2 2021 | 146.3K | $13M | +0.87% |
| Q1 2021 | 146.4K | $13M | +0.84% |
| Q4 2020 | 143.6K | $14M | +0.92% |
| Q3 2020 | 143.3K | $12M | +0.91% |
| Q2 2020 | 144.8K | $13M | +1.01% |
| Q1 2020 | 145.9K | $12M | +1.11% |
| Q4 2019 | 147.2K | $14M | +1.09% |
| Q3 2019 | 149.3K | $13M | +1.07% |
| Q2 2019 | 147.5K | $13M | +1.15% |
| Q1 2019 | 146.5K | $14M | +1.25% |
| Q4 2018 | 141.8K | $12M | +1.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gamble Jones Investment Counsel’s full portfolio or all institutional holders of NVSN.